SLC43A1 and colorectal carcinoma: In vitro studies indicate that cell lines across tumor types and CRC cell lines that are responsive to oxaliplatin have increased levels of LAT3 compared to those that are more resistant, further suggesting a LAT3-mediated mechanism for oxaliplatin resistance.